Swiss National Bank Homology Medicines, Inc. Transaction History

Swiss National Bank

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$1.39 - $3.12 $116,898 - $262,392	-84,100 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$6.02 - $9.64 $198,660 - $318,120	33,000 Added 64.58%	84,100 $611,000
Q4 2020 Feb 05, 2021	SELL	$8.92 - $13.29 $47,276 - $70,437	-5,300 Reduced 9.4%	51,100 $577,000
Q3 2020 Nov 09, 2020	BUY	$9.94 - $16.59 $22,862 - $38,157	2,300 Added 4.25%	56,400 $603,000
Q2 2020 Aug 05, 2020	BUY	$12.07 - $19.34 $195,534 - $313,308	16,200 Added 42.74%	54,100 $822,000

Q4 2019 Feb 06, 2020	BUY	$11.42 - $22.19 $19,414 - $37,723	1,700 Added 4.7%	37,900 $785,000
Q2 2019 Aug 02, 2019	BUY	$18.35 - $30.34 $238,550 - $394,420	13,000 Added 56.03%	36,200 $708,000
Q4 2018 Feb 13, 2019	BUY	$18.39 - $26.3 $426,648 - $610,160	23,200 New	23,200 $519,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.